Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis

Physiological Research

Volumn 56, Issue 6, 2007, Pages 771-777

  Senolt L ^a,b   Braun, M ^a   Vencovsky J ^a   Sedova L ^a   Pavelka, K ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Advanced glycation end product (AGE); Anti CCP antibodies; Cartilage oligomeric matrix protein (COMP); Pentosidine; Rheumatoid arthritis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; BIOLOGICAL MARKER; CARTILAGE MATRIX PROTEIN; DRUG DERIVATIVE; GLYCOPROTEIN; LYSINE; PENTOSIDINE; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ARTICULAR CARTILAGE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARGININE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; LYSINE; MALE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 41749100431     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ARNETT FC, EDWORTHY SM, BLOCH DA, MCSHANE DJ, FRIES JF, COOPER NS, HEALEY LA, KAPLAN SR, LIANG MH, LUTHRA HS: The American Rheumatism Association 1987 Revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324, 1988.
2. CHEN JR, TAKAHASHI M, SUZUKI M, KUSHIDA K, MIYAMOTO S, INOUE T: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis. J Rheumatol 25: 2440-2444, 1998.
3. CHEN JR, TAKAHASHI M, SUZUKI M, KUSHIDA K, MIYAMOTO S, INOUE T: Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 38: 1275-1278, 1999.
4. CRNKIC M, MANSSON B, LARSSON L, GEBOREK P, HEINEGARD D, SAXNE T: Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept. Arthritis Res Ther 5: R181-185, 2003.
5. DEGROOT J, VERZIJL N, WENTING-VAN WIJK MJ, JACOBS KM, VAN EL B, VAN ROERMUND PM, BANK RA, BIJLSMA JW, TEKOPPELE JM, LAFEBER FP: Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 50: 1207-1215, 2004.
6. DRINDA S, FRANKE S, CANET CC, PETROW P, BRAUER R, HUTTICH C, STEIN G, HEIN G: Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Ann Rheum Dis 61: 488-492, 2002.
7. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469, 1993.
8. FORSLIND K, EBERHARDT K, JONSSON A, SAXNE T: Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 31: 593-598, 1992.
9. HEIN GE, KOHLER M, OELZNER P, STEIN G, FRANKE S: The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int 26: 137-141, 2004.
10. HITCHON CA, EL-GABALAWY HS: Oxidation in rheumatoid arthritis. Arthritis Res Ther 6: 265-278, 2004.
11. KAROUZAKIS E, NEIDHART M, GAY RE, GAY S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 106: 8-13, 2006.
12. LOESER RF, YAMMANI RR, CARLSON CS, CHEN H, COLE A, IM HJ, BURSCH LS, YAN SD: Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum 52: 2376-2385, 2005.
13. LUCEY MD, NEWKIRK MM, NEVILLE C, LEPAGE K, FORTIN PR: Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis. J Rheumatol 27: 319-323, 2000.
14. MIYATA T, UEDA Y, SHINZATO T, IIDA Y, TANAKA S, KUROKAWA K, VAN YPERSELE DE STRIHOU C, MAEDA K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7: 1198-1206, 1996.
15. MIYATA T, ISHIGURO N, YASUDA Y, ITO T, NANGAKU M, IWATA H, KUROKAWA K: Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 244: 45-49, 1998.
16. MONNIER VM, SELL DR, NAGARAJ RH, MIYATA S, GRANDHEE S, ODETTI P, IBRAHIM SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41: 36-41, 1992.
17. NEIDHART M, HAUSER N, PAULSSON M, DICESARE PE, MICHEL BA, HAUSELMANN HJ: Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36: 1151-1160, 1997.
18. NEWKIRK MM, GOLDBACH-MANSKY R, LEE J, HOXWORTH J, MCCOY A, YARBORO C, KLIPPEL J, ELGABALAWY HS: Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res Ther 5: R82-90, 2003.
19. PAVELKA K, FOREJTOVÁ S, OLEJÁROVÁ M, GATTEROVÁ J, ŠENOLT L, ŠPAČEK P, BRAUN M, HULEJOVÁ M, ŠTOVÍČKOVÁ J, PAVELKOVÁ A: Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 12: 277-283, 2004.
20. PREVOO ML, VAN 'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB, VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38: 44-48, 1995.
21. RAMEY DR, RAYNAULD JP, FRIES JF: The health assessment questionnaire 1992: status and review. Arthritis Care Res 5: 119-129, 1992.
22. RAZA K, BREESE M, NIGHTINGALE P, KUMAR K, POTTER T, CARRUTHERS DM, SITUNAYAKE D, GORDON C, BUCKLEY CD, SALMON M, KITAS GD: Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32: 231-238, 2005.
23. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264: 21597-21602, 1989.
24. SMITH MA, TANEDA S, RICHEY PL, MIYATA S, YAN SD, STERN D, SAYRE LM, MONNIER VM, PERRY G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714, 1994.
25. STANCZYK J, OSPELT C, GAY RE, GAY S: Synovial cell activation. Curr Opin Rheumatol 18: 262-267, 2006.
26. STEENVOORDEN MM, HUIZINGA TW, VERZIJL N, BANK RA, RONDAY HK, LUNING HA, LAFEBER FP, TOES RE, DEGROOT J: Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 54: 253-263, 2006.
27. ŠENOLT L, BRAUN M, OLEJÁROVÁ M, FOREJTOVÁ S, GATTEROVÁ J, PAVELKA K: Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 64: 886-890, 2005.
28. ŠPAČ̀EK P, ADAM M: HPLC method for pentosidine determination in urine, serum, and tissues as a marker of glycation and oxidation loading of the organism. J Liq Chrom Rel Technol 25: 1807-1820, 2002.
29. TAKAHASHI M, KUSHIDA K, OHISHI T, KAWANA K, HOSHINO H, UCHIYAMA A, INOUE T: Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum 37: 724-728, 1994.
30. TAKAHASHI M, SUZUKI M, KUSHIDA K, MIYAMOTO S, INOUE T: Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br J Rheumatol 36: 637-642, 1997.
31. VENCOVSKÝ J, MACHÁČEK S, ŠEDOVÁ L, KAFKOVÁ J, GATTEROVÁ J, PEŠÁKOVÁ V, RŮŽIČKOVÁ S: Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62: 427-430, 2003.
32. VERZIJL N, DEGROOT J, OLDEHINKEL E, BANK RA, THORPE SR, BAYNES JW, BAYLISS MT, BIJLSMA JW, LAFEBER FP, TEKOPPELE JM: Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 350: 381-387, 2000.
33. VERZIJL N, BANK RA, TEKOPPELE JM, DEGROOT J: AGEing and osteoarthritis: a different perspective. Curr Opin Rheumatol 15: 616-622, 2003.
34. VILÍM V, VOBURKA Z, VYTÁŠEK R, ŠENOLT L, TCHETVERIKOV I, KRAUS VB, PAVELKA K: Monoclonal antibodies to human cartilage oligomeric matrix protein: epitope mapping and characterization of sandwich ELISA. Clin Chim Acta 328: 59-69, 2003.